Allied Market Research published a report, titled, "Angioplasty Balloons Market by Type (Normal Balloons, Drug Eluting ...

Please provide your email address to receive an email when new articles are posted on . A sirolimus-eluting balloon was noninferior to drug-eluting stents in treating de novo coronary lesions. The ...

New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout ...

In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and effective outcomes. Their minimally invasive nature makes them a viable ...

Please provide your email address to receive an email when new articles are posted on . A paclitaxel-coated balloon bested conventional angioplasty in treating coronary in-stent restenosis. The coated ...

LONDON -- Drug-coated balloon (DCB) angioplasty as the initial strategy for de novo coronary artery stenoses didn't measure up to stenting from the start, the REC-CAGEFREE I randomized trial showed.

European Journal of Vascular and Endovascular Surgery Publishes Results Showing Comparable Safety and Efficacy of SurVeil™ DCB Despite IN.PACT™ Admiral™ DCB having 75% Higher Paclitaxel Dose. EDEN ...

SAN FRANCISCO — A sirolimus-eluting balloon was found to be noninferior to conventional stenting in separate trials of patients undergoing percutaneous coronary interventions (PCIs), suggesting these ...

Jerry Bailey was awake while a medical team at OhioHealth Mansfield Hospital reopened one of his previously stented arteries using a new heart procedure. "It's working," the 73-year-old said a few ...